{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Analysis Part II\n",
    "Is the same method applicable to the two intermediate endpoints, symptoms within 1 week and symptoms after 1 week? If so, how? Identify any additional assumptions or adjustments that would be required to use the method on the intermediate endpoints. If the method is not applicable to the intermediate endpoints, explain why."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Analysis Part III\n",
    "\n",
    "Imagine enumerating all the subject-weeks (4 weeks per subject), and labeling each as either “has symptoms” or “does not have symptoms,” so that each week is labeled with a binary outcome. Can either of the methods you implemented be used to find confidence bounds for the average treatment effect, measured as the reduction in the average number of symptomatic weeks per subject? If so, explain how; if not, explain why."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Analysis Part IV\n",
    "Read the safety information and the information about the subjects in the press release, including information about race, age, and risk factors. Based on the evidence in the press release, would you recommend this prophylactic treatment to a friend or relative? Why or why not? Is there something else you would want to know first? If so, what?"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
